Applications of fluorine-containing amino acids for drug design
Fluorine-containing amino acids are becoming increasingly prominent in new drugs due to
two general trends in the modern pharmaceutical industry. Firstly, the growing acceptance of …
two general trends in the modern pharmaceutical industry. Firstly, the growing acceptance of …
Kinin B1 receptors as a therapeutic target for inflammation
F Qadri, M Bader - Expert opinion on therapeutic targets, 2018 - Taylor & Francis
Introduction: Kinins are peptide mediators exerting their pro-inflammatory actions by the
selective stimulation of two distinct G-protein coupled receptors, termed BKB1R and BKB2R …
selective stimulation of two distinct G-protein coupled receptors, termed BKB1R and BKB2R …
Enantioselective rhodium-catalyzed addition of potassium alkenyltrifluoroborates to cyclic imines
Y Luo, AJ Carnell, HW Lam - Angewandte Chemie International …, 2012 - research.ed.ac.uk
Cyclic imines, in which the C [DOUBLE BOND] N bond is constrained in the Z geometry,
have been identified as highly effective substrates for enantioselective rhodium-catalyzed …
have been identified as highly effective substrates for enantioselective rhodium-catalyzed …
Cyclic aldimines as superior electrophiles for Cu-catalyzed decarboxylative Mannich reaction of β-ketoacids with a broad scope and high enantioselectivity
HX Zhang, J Nie, H Cai, JA Ma - Organic letters, 2014 - ACS Publications
A novel Cu-catalyzed enantioselective decarboxylative Mannich reaction of cyclic aldimines
with β-ketoacids is described. The cyclic structure of these aldimines, in which the C N …
with β-ketoacids is described. The cyclic structure of these aldimines, in which the C N …
Catalytic Asymmetric Decarboxylative Mannich Reaction of Malonic Acid Half Esters with Cyclic Aldimines: Access to Chiral β-Amino Esters and Chroman-4-amines
CM Jia, HX Zhang, J Nie, JA Ma - The Journal of Organic …, 2016 - ACS Publications
An enantioselective decarboxylative Mannich reaction of malonic acid half esters (MAHEs)
with cyclic aldimines has been accomplished by employing the copper (I)/(R, R)-Ph-Box …
with cyclic aldimines has been accomplished by employing the copper (I)/(R, R)-Ph-Box …
Copper(I)‐Photocatalyzed Diastereoselective Aziridination of N‐Sulfonyl Imines with Vinyl Azides: Application to Benzo[f][1,2,3]oxathiazepines Dioxides and Fused …
S Banuprakash Goud, R Lal Dhakar… - Chemistry–An Asian …, 2024 - Wiley Online Library
An in situ generated photoactive copper (I)‐complex‐catalyzed aziridination reaction of
cyclic N‐sulfonyl imines with α‐aryl‐substituted vinyl azides irradiated by blue‐LEDs light is …
cyclic N‐sulfonyl imines with α‐aryl‐substituted vinyl azides irradiated by blue‐LEDs light is …
Discovery of dihydroquinoxalinone acetamides containing bicyclic amines as potent Bradykinin B1 receptor antagonists
JJ Chen, W Qian, K Biswas, VN Viswanadhan… - Bioorganic & medicinal …, 2008 - Elsevier
Replacement of the core β-amino acid in our previously reported piperidine acetic acid and
β-phenylalanine-based Bradykinin B1 antagonists by dihydroquinoxalinone acetic acid …
β-phenylalanine-based Bradykinin B1 antagonists by dihydroquinoxalinone acetic acid …
Bradykinin B1 receptor antagonists as potential therapeutic agents for pain
H Huang, MR Player - Journal of medicinal chemistry, 2010 - ACS Publications
The Kinin Family. Kinins are naturally occurring vasoactive peptide hormones, which are
known to be important mediators of a variety of biological effects, including cardiovascular …
known to be important mediators of a variety of biological effects, including cardiovascular …
Discovery of potent, orally bioavailable phthalazinone bradykinin B1 receptor antagonists
K Biswas, TAN Peterkin, MC Bryan, L Arik… - Journal of medicinal …, 2011 - ACS Publications
The bradykinin B1 receptor is rapidly induced upon tissue injury and inflammation,
stimulating the production of inflammatory mediators resulting in plasma extravasation …
stimulating the production of inflammatory mediators resulting in plasma extravasation …
Bradykinin receptor antagonists–a review of the patent literature 2005–2008
CI Fincham, A Bressan, M Paris, C Rossi… - Expert opinion on …, 2009 - Taylor & Francis
Background: For> 20 years, pharmaceutical companies and academic centers have been
developing bradykinin antagonists. The patent literature on these molecules (up to and …
developing bradykinin antagonists. The patent literature on these molecules (up to and …